share_log

Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jun 4 06:31
Summary by Futu AI
Eli Lilly and Co officer, Zakrowski Donald A, is set to sell 750 shares of the company's common stock on 06/03/2024, as per the latest filing. The shares, valued at an aggregate market value of $614,602.5, were originally acquired on 02/10/2023 through the vesting of a performance share unit award, part of the issuer's equity compensation plan. This transaction follows a similar sale of 750 shares on 03/11/2024, which grossed $565,200. The upcoming sale reflects ongoing transactions by company insiders, providing investors with insights into executive stock dispositions.
Eli Lilly and Co officer, Zakrowski Donald A, is set to sell 750 shares of the company's common stock on 06/03/2024, as per the latest filing. The shares, valued at an aggregate market value of $614,602.5, were originally acquired on 02/10/2023 through the vesting of a performance share unit award, part of the issuer's equity compensation plan. This transaction follows a similar sale of 750 shares on 03/11/2024, which grossed $565,200. The upcoming sale reflects ongoing transactions by company insiders, providing investors with insights into executive stock dispositions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.